Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

GREY:CLAZF - Post Discussion

Claritas Pharmaceuticals Inc > $$$$ Get Ready! Load up!!
View:
Post by BYLowSELHIGH on May 29, 2020 9:07am

$$$$ Get Ready! Load up!!

We are heading NORTH!!
Comment by bud13 on May 29, 2020 9:12am
it will b interesting to c if we move up. Any other company who mentions covid 19 triples in days. Pre bid looks like no movement
Comment by Moonshiner592 on May 29, 2020 9:29am
.. sometimes...(generally speaking)... those pre-bids stay where they are for about 5-10 minutes after opening .. then if the reaction to the news is good... the take off begins... Let's see... GLTA
Comment by bud13 on May 29, 2020 9:33am
2.5m at open at .03
Comment by Davidtepperss62 on May 29, 2020 9:13am
>>>>> KLY  =  0.005¢ soon <<<<<<
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities